We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

BIOSYSTEMS

Biosystems researches, develops, produces and markets a wide range of instruments and reagents for clinical chemistry... read more Featured Products: More products

Download Mobile App





BioSystems Highlights New iFOB Integral System at MedLab 2019

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The new Fecal Occult blood integral system (Photo courtesy of BioSystems).
Image: The new Fecal Occult blood integral system (Photo courtesy of BioSystems).
BioSystems S.A. (Barcelona, Spain) presented its analytical systems at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. MedLab Middle East 2019 attracted more than 19,610 unique visitors and the exhibition floor area housed 678+ exhibitors dedicated to sharing the most recent technology available in the IVD, and medical laboratory market. The MedLab Congress also enjoyed massive growth, welcoming more than 6,000 delegates to the multi-track conferences this year.

At MedLab Middle East 2019, BioSystems presented its new Fecal Occult Blood (iFOB) integral system, which provides a diagnostic solution for FOB testing. Colorectal cancer (CRC) is the third-most common cancer and the fourth-leading cause of cancer-related deaths in the world. CRC is treatable and preventable if it is detected in the early stages, with the detection of fecal occult blood being the key to preventing colorectal cancer.

BioSystems’ new iFOB system is comprised of an easy-to-use stool collection tube for easy sampling at the patient’s home or in the laboratory, an improved immunoturbidimetric assay in the form of a new and high sensitive antibody against human hemoglobin (no cross reaction with non-human Hb), an updated version of the company’s A15 analyzer with a new cap piercing function (no need to decap or recap samples tube after testing), and a dedicated software for fecal samples.

The iFOB system provides an accurate, reliable and safe method for FOB testing, making this test accessible to any kind of laboratory. In addition to FOB tests, BioSystems’ integral system can be updated with new fecal tests such as fecal Calprotectin, Transferrin and Helicobacter pylori, making the system a complete solution for stool samples analysis in the laboratory.

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Unit-Dose Packaging solution
HLX
New
Clostridium Difficile Assay
Revogene C. Difficile
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.